skip to Main Content

Home
Team
Technology
Pipeline
News
Partners
Supports
Contact

Open Mobile Menu

News

WILCO startup cluster

December 5, 2018
tokyonne
News

HEPHAISTOS-Pharma was selected by WILCO startup cluster to obtain capital loans and increase our own funds.

Share This

Tweet
Share
Share
Email

Related Posts

HEPHAISTOS secures €10.3 M to reach the clinical stage

HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a total of €10.3 million from…

Orphan Drug Designation

The European Medicines Agency (EMA) has granted Orphan Drug Designation to ONCO-Boost (HEPHAISTOS-Pharma) as treatment…

HEPHAISTOS-Pharma secures a €2 million seed round

HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq…

next post: European Grant

Home
Team
Technology
Pipeline
News
Partners
Supports
Contact

2025 © HEPHAITOS PHARMA. ALL RIGHTS RESERVED. | Privacy statement

Back To Top